Danaher Drops $10B to Snatch Masimo in Diagnostics Push
Danaher is acquiring Masimo in a $10 billion deal aimed at expanding its diagnostics portfolio and deepening its presence in acute care settings. The move
Danaher is acquiring Masimo in a $10 billion deal aimed at expanding its diagnostics portfolio and deepening its presence in acute care settings. The move
Novartis’s alliance with Unnatural Products is pursuing next-generation peptide drugs for cardiovascular disease. The startup already has drug R&D alliances with BridgeBio Pharma, Merck, and
Instead of adding more layers of complexity to an already strained system, there’s a more effective solution: make it simpler for independent clinicians to run
Imaging has become a core input into how health systems understand disease, evaluate outcomes, plan capacity, and increasingly, how they learn. The post Imaging Data
The head of Anthropic’s biology and life sciences business spoke about introducing “first-party” products, having a presence inside the EHR and what Claude can do
Solera Health has launched a behavioral health network that connects members to partners Calm Health and Lyra Health for digital mental health, coaching and therapy
HealthGility provides healthcare organizations with a solution for patient protected health information disclosure and confidentiality that reduces workloads and ensures the safe and secure sharing of sensitive data between different providers.